Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-06

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating add-on amlodipine besylate with candesartan cilexetil in patients with essential hypertension not adequately controlled on amlodipine a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate and candesartan cilexetil combination

Snippet

Sponsor: HK inno.N Corporation | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED